Sharp Corp. buy krebskrebs
Start price
17.05.22
/
50%
€1.88
Target price
17.05.23
€2.20
Performance (%)
-24.47%
End price
18.05.23
€1.42
Summary
This prediction ended on 18.05.23 with a price of €1.42. The price of Sharp Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.47%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sharp Corp. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by krebskrebs for this prediction
In the thread Sharp Corp. diskutieren
In the thread Trading Sharp Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten